$OSUR
ORASURE TECHNOLOGIES INC Stock $osur

$osur Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-K Financial Statement

#000119312516503534 Filed on March 14, 2016

Income Statement

Concept	2014 Q4	2014 Q3	2014 Q2
Revenue	$28.68M	$27.85M	$26.40M
YoY Change	-0.3%	12.87%	8.48%
Cost Of Revenue	$10.71M	$9.140M	$10.39M
YoY Change	-7.99%	-6.14%	5.56%
Gross Profit	$17.98M	$18.71M	$16.02M
YoY Change	4.96%	25.26%	10.46%
Gross Profit Margin	62.69%	67.18%	60.66%
Selling, General & Admin	$16.72M	$14.83M	$16.25M
YoY Change	-2.51%	3.56%	-6.52%
% of Gross Profit	92.99%	79.3%	101.45%
Research & Development	$3.820M	$2.990M	$2.771M
YoY Change	72.85%	11.99%	2.9%
% of Gross Profit	21.25%	15.99%	17.3%
Depreciation & Amortization	$1.580M	$1.624M	$1.569M
YoY Change	-7.06%	-0.06%	-3.09%
% of Gross Profit	8.79%	8.68%	9.8%
Operating Expenses	$20.53M	$17.82M	$13.52M
YoY Change	5.99%	4.88%	-32.66%
Operating Profit	-$2.563M	$882.0K	$2.497M
YoY Change	-142.27%	-142.82%	-144.78%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$287.0K	$268.0K	-$142.0K
YoY Change	75.0%	553.66%	-438.1%
Pretax Income	-$2.276M	$1.150M	$2.355M
YoY Change	-136.55%	-156.96%	-142.56%
Income Tax	$376.0K	$10.00K	-$174.0K
% Of Pretax Income		0.87%	-7.39%
Net Earnings	-$2.652M	$1.140M	$2.529M
YoY Change	-142.68%	-160.25%	-147.85%
Net Earnings / Revenue	-9.25%	4.09%	9.58%
Basic Earnings Per Share	-$0.05	$0.02	$0.05
Diluted Earnings Per Share	-$0.05	$0.02	$0.04
COMMON SHARES
Basic Shares Outstanding	56.06M shares	56.02M shares	55.91M shares
Diluted Shares Outstanding		56.67M shares	57.24M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$97.90M	$98.90M	$80.30M
YoY Change	5.04%	19.73%	4.29%
Cash & Equivalents	$92.87M	$93.86M	$75.83M
Short-Term Investments	$5.000M	$5.000M	$4.400M
Other Short-Term Assets	$306.0K	$273.0K	$6.627M
YoY Change	53.0%	-46.58%	1715.62%
Inventory	$15.76M	$14.84M	$13.23M
Prepaid Expenses	$1.140M
Receivables	$16.14M	$14.92M	$14.15M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$131.2M	$130.0M	$115.8M
YoY Change	9.73%	16.74%	7.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.93M	$17.96M	$18.47M
YoY Change	0.01%	-0.17%	1.84%
Goodwill	$21.73M	$22.56M	$23.67M
YoY Change	-8.61%	-7.95%	-1.43%
Intangibles	$17.51M	$13.66M	$20.44M
YoY Change	-21.24%	-42.36%	-15.38%
Long-Term Investments
YoY Change
Other Assets	$1.246M	$1.102M	$1.172M
YoY Change	70.92%	79.48%	185.85%
Total Long-Term Assets	$58.42M	$60.45M	$63.76M
YoY Change	-9.67%	-9.52%	-4.44%
TOTAL ASSETS
Total Short-Term Assets	$131.2M	$130.0M	$115.8M
Total Long-Term Assets	$58.42M	$60.45M	$63.76M
Total Assets	$189.6M	$190.5M	$179.6M
YoY Change	2.92%	6.9%	2.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.148M	$4.510M	$4.647M
YoY Change	47.87%	16.87%	37.44%
Accrued Expenses	$11.13M	$9.203M	$9.366M
YoY Change	-14.58%	-16.3%	14.28%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$26.46M	$25.25M	$14.71M
YoY Change	39.38%	30.67%	-7.95%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.234M	$1.090M	$1.157M
YoY Change	82.27%	102.23%	202.09%
Total Long-Term Liabilities	$1.234M	$1.090M	$1.157M
YoY Change	82.27%	102.23%	202.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.46M	$25.25M	$14.71M
Total Long-Term Liabilities	$1.234M	$1.090M	$1.157M
Total Liabilities	$27.70M	$26.34M	$15.86M
YoY Change	40.86%	32.61%	-3.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$178.3M	-$175.7M	-$176.8M
YoY Change	2.66%	-2.36%	-0.68%
Common Stock	$344.9M	$342.9M	$341.1M
YoY Change	1.84%	1.68%	1.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$158.7M	$160.9M	$160.3M
YoY Change
Total Liabilities & Shareholders Equity	$189.6M	$190.5M	$179.6M
YoY Change	2.92%	6.9%	2.95%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2014 Q2
OPERATING ACTIVITIES
Net Income	-$2.652M	$1.140M	$2.529M
YoY Change	-142.68%	-160.25%	-147.85%
Depreciation, Depletion And Amortization	$1.580M	$1.624M	$1.569M
YoY Change	-7.06%	-0.06%	-3.09%
Cash From Operating Activities	-$850.0K	$18.78M	-$2.730M
YoY Change	-107.37%	205.86%	69.57%
INVESTING ACTIVITIES
Capital Expenditures	-$660.0K	$365.0K	$1.341M
YoY Change	-13.16%	-39.57%	119.12%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$550.0K	-$4.430M
YoY Change
Cash From Investing Activities	-$650.0K	-$910.0K	-$5.770M
YoY Change	-14.47%	49.18%	845.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	570.0K	350.0K	-10.00K
YoY Change	612.5%		-83.33%
NET CHANGE
Cash From Operating Activities	-850.0K	18.78M	-2.730M
Cash From Investing Activities	-650.0K	-910.0K	-5.770M
Cash From Financing Activities	570.0K	350.0K	-10.00K
Net Change In Cash	-930.0K	18.22M	-8.510M
YoY Change	-108.57%	229.48%	273.25%
FREE CASH FLOW
Cash From Operating Activities	-$850.0K	$18.78M	-$2.730M
Capital Expenditures	-$660.0K	$365.0K	$1.341M
Free Cash Flow	-$190.0K	$18.42M	-$4.071M
YoY Change	-101.55%	232.64%	83.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2008Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178345000
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55482238	shares
CY2000Q3	osur	Net Operating Loss Carry Forward Limit For Utilization Amount NetOperatingLossCarryForwardLimitForUtilizationAmount	13700000
CY2015Q2	dei	Entity Public Float EntityPublicFloat	298662067
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4644000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.64
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	670000	shares
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	170315000
CY2013Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2011000
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87888000
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5271000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.54
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	653000	shares
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	161146000
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2051000
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-3131000
CY2013Q4	us-gaap	Goodwill Goodwill	23782000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93191000
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5740000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.22
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	707000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56187000	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56187000	shares
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.000001
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3375000
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	344894000
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1747000
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6620000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	158701000
CY2014Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	3978000
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1234000
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	480000
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16227000
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2073000
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	8043000
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7148000
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	533000
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11132000
CY2014Q4	us-gaap	Purchase Obligation PurchaseObligation	4488000
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	189633000
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	139000
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	31416000
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	26462000
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	44072000
CY2014Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	485000
CY2014Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1234000
CY2014Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2285000
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-4051000
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7848000
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3236000
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	8539000
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	28547000
CY2014Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1758000
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	40697000
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1246000
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5369000
CY2014Q4	us-gaap	Assets Assets	189633000
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17505000
CY2014Q4	us-gaap	Inventory Net InventoryNet	15763000
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16138000
CY2014Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	597000
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17934000
CY2014Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	1234000
CY2014Q4	us-gaap	Assets Current AssetsCurrent	131214000
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	306000
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	33732000
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6326000
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2528000
CY2014Q4	us-gaap	Goodwill Goodwill	21734000
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	898000
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1140000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92867000
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49350000
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	5000000
CY2014Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1833000
CY2014Q4	osur	Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts	4528000
CY2015Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	4562000	shares
CY2015Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	7.40
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	697000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55705000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3696000	shares
CY2015Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	7.46
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	7.45
CY2015Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	6216000	shares
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000001
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4562000	shares
CY2015Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	500000
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55705000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.40
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2488000
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6216000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.46
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.000001
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6179000	shares
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	355000
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	362000
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2883000
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	345253000
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2268000
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6311000
CY2015Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	500000
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	159436000
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	362000
CY2015Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	2725000
CY2015Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	292000
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1768000
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1014000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12359000
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2088000
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	9735000
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5087000
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	798000
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10412000
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-170178000
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	189321000
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	334000
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	33013000
CY2015Q4	us-gaap	Contractual Obligation ContractualObligation	1292000
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	724000
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25234000
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	42250000
CY2015Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	367000
CY2015Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1324000
CY2015Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	819000
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-7791000
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-15639000
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	351000
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2883000
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	7895000
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1914000
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	21985000
CY2015Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1725000
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	39367000
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1683000
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2397000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6371000
CY2015Q4	us-gaap	Assets Assets	189321000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2701000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2704000
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12591000
CY2015Q4	us-gaap	Inventory Net InventoryNet	13242000
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19265000
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20083000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2704000
CY2015Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	1324000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1372000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1451000
CY2015Q4	us-gaap	Assets Current AssetsCurrent	136714000
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1355000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	24950000
CY2015Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	62962000
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5014000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	5782000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12591000
CY2015Q4	us-gaap	Goodwill Goodwill	18250000
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	333000
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1533000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94094000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1659000
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	53096000
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	7225000
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2405000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1885000
CY2015Q4	osur	Deferred Tax Liabilities Tax Credit Carryforwards DeferredTaxLiabilitiesTaxCreditCarryforwards	92000
CY2015Q4	osur	Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts	4803000
CY2015Q4	osur	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber	697000	shares
CY2015Q2	osur	Contract Expiration Period ContractExpirationPeriod	P3Y
CY2015Q2	osur	Maximum Contract Revenue From Clinical And Regulatory Activities MaximumContractRevenueFromClinicalAndRegulatoryActivities	10400000
CY2015Q2	osur	Initial Contract Revenue From Clinical And Regulatory Activities InitialContractRevenueFromClinicalAndRegulatoryActivities	1800000
CY2015Q2	osur	Remaining Contract Revenue From Clinical And Regulatory Activities RemainingContractRevenueFromClinicalAndRegulatoryActivities	8600000
CY2000Q3	osur	Number Of Companies Merged NumberOfCompaniesMerged	2	Companies
CY2013Q4	osur	Accruals For Purchase Of Property Plant And Equipment AccrualsForPurchaseOfPropertyPlantAndEquipment	0
CY2014Q4	osur	Accruals For Purchase Of Property Plant And Equipment AccrualsForPurchaseOfPropertyPlantAndEquipment	217000
CY2015Q4	osur	Accruals For Purchase Of Property Plant And Equipment AccrualsForPurchaseOfPropertyPlantAndEquipment	1370000
CY2015Q3	osur	Additional Contract Revenue From Clinical And Regulatory Activities AdditionalContractRevenueFromClinicalAndRegulatoryActivities	7200000
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	8385000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	82000	shares
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.090	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	438000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0147	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	195000	shares
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.009	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	60000	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.87
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	395000	shares
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	7.59
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.384	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.028	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.94
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55555000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	984000	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.07
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55555000	shares
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-420000
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10932000
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	80000	shares
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	18000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.51	pure
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.065	pure
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2462000
CY2013	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	8300000
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-11190000
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	409000
CY2013	us-gaap	Revenues Revenues	98940000
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-51000
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	829000
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-12162000
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1268000
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	27000
CY2013	us-gaap	Gross Profit GrossProfit	58589000
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	200000
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-4603000
CY2013	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4337000
CY2013	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2694000
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	68000
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14321000
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3131000
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	40000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11962000
CY2013	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	2878000
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	98317000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-10554000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1408000
CY2013	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	623000
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-49000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11962000
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-772000
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	5572000
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4280000
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-323000
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4365000
CY2013	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	46465000
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	600000
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5303000
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-772000
CY2013	us-gaap	Operating Expenses OperatingExpenses	70751000
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2462000
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	40351000
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1510000
CY2013	us-gaap	Depreciation Depreciation	3026000
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6552000
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-772000
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	553000
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5373000
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	409000
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2665000
CY2013	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	829000
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21654000
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-200000
CY2013	us-gaap	Advertising Expense AdvertisingExpense	17142000
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3526000
CY2013	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	772000
CY2013	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	0
CY2013	osur	Deferred Income Tax Expense Benefit Before Valuation Allowance DeferredIncomeTaxExpenseBenefitBeforeValuationAllowance	-5375000
CY2013	osur	Allocated Share Based Compensation Expense Amounts Capitalized Into Inventory AllocatedShareBasedCompensationExpenseAmountsCapitalizedIntoInventory	128000
CY2013	osur	Allocated Share Based Compensation Expense Cost Of Sales AllocatedShareBasedCompensationExpenseCostOfSales	99000
CY2013	osur	Stock Option Plan Gross Expense Arising From Equity Based Compensation StockOptionPlanGrossExpenseArisingFromEquityBasedCompensation	2694000
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	7526000
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	388000	shares
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.280	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	506000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0213	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	96000	shares
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.115	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	24000	shares
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.43
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	428000	shares
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	8.38
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.720	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.135	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.77
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55949000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1202000	shares
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	49000
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	6943000
CY2014	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	41118000
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	648000
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.09
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55949000	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	249000	shares
CY2014	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	253000
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.50	pure
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.080	pure
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3005000
CY2014	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	5500000
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-4614000
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1115000
CY2014	us-gaap	Revenues Revenues	106464000
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-475000
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	639000
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-4802000
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4401000
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	31000
CY2014	us-gaap	Gross Profit GrossProfit	66624000
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	531000
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-3075000
CY2014	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3381000
CY2014	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	3081000
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	273000
CY2014	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	9407000
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8665000
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4051000
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	25000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4271000
CY2014	us-gaap	Revenue Recognition Sales Returns Reserve For Sales Returns RevenueRecognitionSalesReturnsReserveForSalesReturns	437000
CY2014	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	2663000
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	98894000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-6156000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1885000
CY2014	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	7570000
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	305000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4271000
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	343000
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	5744000
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3000
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2248000
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-827000
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-324000
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	294000
CY2014	us-gaap	Operating Expenses OperatingExpenses	71426000
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-7980000
CY2014	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-2048000
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	476000
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12058000
CY2014	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	294000
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	565000
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1730000
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1115000
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3061000
CY2014	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	639000
CY2014	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	4432000
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23750000
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-346000
CY2014	us-gaap	Advertising Expense AdvertisingExpense	6910000
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	49000
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3184000
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	39840000
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2194000
CY2014	us-gaap	Depreciation Depreciation	3123000
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6307000
CY2014	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	343000
CY2014	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	0
CY2014	osur	Deferred Income Tax Expense Benefit Before Valuation Allowance DeferredIncomeTaxExpenseBenefitBeforeValuationAllowance	-2781000
CY2014	osur	Allocated Share Based Compensation Expense Amounts Capitalized Into Inventory AllocatedShareBasedCompensationExpenseAmountsCapitalizedIntoInventory	148000
CY2014	osur	Allocated Share Based Compensation Expense Cost Of Sales AllocatedShareBasedCompensationExpenseCostOfSales	128000
CY2014	osur	Stock Option Plan Gross Expense Arising From Equity Based Compensation StockOptionPlanGrossExpenseArisingFromEquityBasedCompensation	3081000
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	15773000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	163000	shares
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.131	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	362000	shares
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0149	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	60000	shares
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.057	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0001116463
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	18000	shares
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M6D
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.07
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <i>Deferred Revenue</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt" align="justify">We record deferred revenue when funds are received prior to the recognition of the associated revenue. Deferred revenue as of December 31, 2015 and 2014 includes customer prepayments of $784 and $613, respectively. Deferred revenue as of December 31, 2015 and 2014 also includes $8,951 and $7,430, respectively, from AbbVie, which represents the excess of the payments received from AbbVie over the amounts earned and recognized ratably in our consolidated statement of operations.</p> </div>
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward	Options generally vest over four years, with one quarter of the options vesting one year after grant and the remainder vesting on a monthly basis over the next three years.
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	354000	shares
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	8.55
CY2015	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	774000
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.206	pure
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.015	pure
CY2015	dei	Trading Symbol TradingSymbol	OSUR
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.75	pure
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.28
CY2015	dei	Entity Registrant Name EntityRegistrantName	ORASURE TECHNOLOGIES INC
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56846000	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	449000	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	773000	shares
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.46
CY2015	us-gaap	Revenue Recognition Sales Returns RevenueRecognitionSalesReturns	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <i>Customer Sales Returns and Allowances</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt" align="justify">We do not grant product return rights to our customers for any product, except for our OraQuick<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">®</sup> In-Home HIV test. Accordingly, we have recorded an estimate of expected returns as a reduction of gross OraQuick<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">®</sup> In-Home HIV product revenues in our consolidated statement of operations. This estimate reflects our historical sales experience to retailers and consumers, as well as other retail factors, and is reviewed regularly to ensure that it reflects potential product returns. As of December 31, 2015 and 2014, the reserve for sales returns and allowances was $310 and $437, respectively. If actual product returns differ materially from our reserve amount, or if a determination is made that this product’s distribution would be discontinued in whole or in part by certain retailers, then we would need to adjust our reserve. Should the actual level of product returns vary significantly from our estimates, our operating and financial results could be materially affected.</p> </div>
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56397000	shares
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <i>Use of Estimates</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt" align="justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the valuation of accounts receivable and inventories and assumptions utilized in impairment testing for intangible assets and goodwill, as well as calculations related to contingencies and accruals, among others. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis, using historical experience and other factors, which management believes to be reasonable under the circumstances, including the current economic environment. We adjust such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity and foreign currency markets, reductions in government funding, and declines in consumer spending have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment and other factors will be reflected in the financial statements in those future periods.</p> </div>
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	74000	shares
CY2015	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	341000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.51	pure
CY2015	us-gaap	Gross Profit GrossProfit	80293000
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.075	pure
CY2015	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y10M24D
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3744000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	8167000
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	404000
CY2015	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-80000
CY2015	us-gaap	Revenues Revenues	119719000
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1415000
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6090000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	8058000
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2348000
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	719000
CY2015	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	23934000
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1822000
CY2015	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3739000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	3403000
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1005000
CY2015	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	26895000
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	376000
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-7791000
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	22000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8832000
CY2015	us-gaap	Revenue Recognition Sales Returns Reserve For Sales Returns RevenueRecognitionSalesReturnsReserveForSalesReturns	310000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	2642000
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	104458000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	5302000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3530000
CY2015	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	15261000
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-367000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8832000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	665000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	6045000
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	7000
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1511000
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	311000
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	617000
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1706000
CY2015	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	35088000
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	731000
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1227000
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	48000
CY2015	us-gaap	Operating Expenses OperatingExpenses	72235000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-6705000
CY2015	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	4000
CY2015	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-3484000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-5686000
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11654000
CY2015	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	48000
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	587000
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-992000
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	404000
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3403000
CY2015	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	6090000
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25493000
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2155000
CY2015	us-gaap	Advertising Expense AdvertisingExpense	623000
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	617000
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2704000
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	39426000
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2648000
CY2015	us-gaap	Depreciation Depreciation	2992000
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5696000
CY2015	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	665000
CY2015	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	0
CY2015	osur	Vendor Supply Continuance Period VendorSupplyContinuancePeriod	P5Y
CY2015	osur	Deferred Rent Expense DeferredRentExpense	110000
CY2015	osur	Deferred Income Tax Expense Benefit Before Valuation Allowance DeferredIncomeTaxExpenseBenefitBeforeValuationAllowance	1870000
CY2015	osur	Allocated Share Based Compensation Expense Amounts Capitalized Into Inventory AllocatedShareBasedCompensationExpenseAmountsCapitalizedIntoInventory	153000
CY2015	osur	Rights Agreement Expiration Date RightsAgreementExpirationDate	2019-12-31
CY2015	osur	Allocated Share Based Compensation Expense Cost Of Sales AllocatedShareBasedCompensationExpenseCostOfSales	153000
CY2015	osur	Stock Option Plan Gross Expense Arising From Equity Based Compensation StockOptionPlanGrossExpenseArisingFromEquityBasedCompensation	3403000
CY2015	osur	Termination Agreement Date TerminationAgreementDate	2013-11-21
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-5631000
CY2014Q1	us-gaap	Revenues Revenues	23537000
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5618000
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	118000
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5500000
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	131000
CY2014Q1	us-gaap	Costs And Expenses CostsAndExpenses	29155000
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	113000
CY2015Q1	us-gaap	Revenues Revenues	27088000
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-291000
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	409000
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	118000
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5000
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	27379000
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2014Q2	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	5500000
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	2529000
CY2014Q2	us-gaap	Revenues Revenues	26401000
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2497000
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-142000
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2355000
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-174000
CY2014Q2	us-gaap	Costs And Expenses CostsAndExpenses	23904000
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	1968000
CY2015Q2	us-gaap	Revenues Revenues	30388000
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2721000
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-95000
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2626000
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	658000
CY2015Q2	us-gaap	Costs And Expenses CostsAndExpenses	27667000
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	1140000
CY2014Q3	us-gaap	Revenues Revenues	27845000
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	882000
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	268000
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1150000
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000
CY2014Q3	us-gaap	Costs And Expenses CostsAndExpenses	26963000
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	1470000
CY2015Q3	us-gaap	Revenues Revenues	29861000
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1536000
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	81000
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1617000
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	147000
CY2015Q3	us-gaap	Costs And Expenses CostsAndExpenses	28325000
CY2013Q4	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	8300000
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-2652000
CY2014Q4	us-gaap	Revenues Revenues	28681000
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2563000
CY2014Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	287000
CY2014Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2276000
CY2014Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	376000
CY2014Q4	us-gaap	Costs And Expenses CostsAndExpenses	31244000
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	4616000
CY2015Q4	us-gaap	Revenues Revenues	32382000
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	4092000
CY2015Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	379000
CY2015Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4471000
CY2015Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-145000
CY2015Q4	us-gaap	Costs And Expenses CostsAndExpenses	28290000

Files In Submission

Name	View Source	Status
0001193125-16-503534-index-headers.html	Edgar Link	pending
0001193125-16-503534-index.html	Edgar Link	pending
0001193125-16-503534.txt	Edgar Link	pending
0001193125-16-503534-xbrl.zip	Edgar Link	pending
d111696d10k.htm	Edgar Link	pending
d111696dex1024.htm	Edgar Link	pending
d111696dex1025.htm	Edgar Link	pending
d111696dex23.htm	Edgar Link	pending
d111696dex24.htm	Edgar Link	pending
d111696dex311.htm	Edgar Link	pending
d111696dex312.htm	Edgar Link	pending
d111696dex321.htm	Edgar Link	pending
d111696dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g111696g52f74.jpg	Edgar Link	pending
osur-20151231.xml	Edgar Link	completed
osur-20151231.xsd	Edgar Link	pending
osur-20151231_cal.xml	Edgar Link	unprocessable
osur-20151231_def.xml	Edgar Link	unprocessable
osur-20151231_lab.xml	Edgar Link	unprocessable
osur-20151231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OSUR
ORASURE TECHNOLOGIES INC Stock $osur

2014 Q4 Form 10-K Financial Statement

#000119312516503534 Filed on March 14, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OSUR ORASURE TECHNOLOGIES INC Stock $osur

2014 Q4 Form 10-K Financial Statement

#000119312516503534 Filed on March 14, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OSUR
ORASURE TECHNOLOGIES INC Stock $osur